<p>Health In Tech NASDAQ: HIT 報告了 2026 年第一季度的收入增長和更大的虧損，管理層表示公司正在有意增加對銷售分銷、承運人關係和技術開發的投資，以追求更大份額的自籌資金健康保險市場。</p>
<p>獲取 <strong>Health In Tech</strong> 警報：</p>
<p>在公司的財報電話會議上，首席執行官 Tim Johnson 表示，Health In Tech 正在一個他所描述的 “龐大且不透明” 的自籌資金止損保險市場中運營，在這個市場中，大型企業的採用率遠高於中小型企業。根據行業估計，Johnson 表示截至 2025 年，約 80% 的大型企業已採用自籌資金健康計劃，而中小型企業的比例約為 27%。</p>
<p>Johnson 表示，公司基於人工智能的平台旨在減少實施自籌資金計劃的複雜性。他表示，Health In Tech 目前與約 900 個分銷合作伙伴合作，主要是保險經紀人，而根據行業估計，保險經紀人的總數超過 100 萬。</p>
<p>“我們在經紀人池中的滲透率仍遠低於千分之一，這突顯了前方巨大的增長潛力，” Johnson 説。</p>
<h2>收入增長，公司重申全年展望</h2>
<p>首席財務官 Julia Qian 表示，2026 年第一季度的總收入為 880 萬美元，比去年同期增長約 9%。調整後的 EBITDA 為負 130 萬美元，而去年同期為正 120 萬美元。淨虧損為 160 萬美元，而去年同期淨收入為 50 萬美元。</p>
<p>Qian 表示，相較於之前的時期，收入增長放緩反映了當前業務擴展階段，而不是需求或平台可擴展性的變化。她表示，收入增長與分銷網絡的擴展、經紀人活動和管道機會的轉化相關，公司在 2026 年將對此進行投資。</p>
<p>Health In Tech 重申其 2026 年全年收入指引為 4500 萬美元至 5000 萬美元，Johnson 表示這將代表約 35% 至 50% 的同比增長。</p>
<p>公司在季度末擁有 1030 萬美元的現金及現金等價物，反映了在 3 月份完成的公開股權私募投資（PIPE）的收益。Johnson 表示，此次融資帶來了約 700 萬美元的毛收益，並不是出於對營運資金的迫切需求。相反，他表示公司看到了擴大股東基礎和為增長計劃增加資本的機會。</p>
<h2>運營費用因計劃投資而增加</h2>
<p>Qian 表示，季度總運營費用為 670 萬美元，約佔收入的 76%，而去年同期為 490 萬美元，約佔收入的 41%。</p>
<ul>
<li>銷售和營銷費用為 230 萬美元，約佔收入的 26%，高於去年同期的 110 萬美元，約佔收入的 14%。</li>
<li>一般和行政費用為 350 萬美元，約佔收入的 39%，而去年同期為 320 萬美元，約佔收入的 41%。</li>
<li>研發費用為 90 萬美元，約佔收入的 10%，而去年同期為 50 萬美元，約佔收入的 7%。</li>
</ul>
<p>Qian 表示，公司在第一季度還資本化了約 60 萬美元的軟件開發費用。她表示，整體費用反映了向增長計劃 “有目的的資本配置轉變”，並預計在 2026 年將繼續保持高水平的投資。</p>
<p>在問答環節中，Qian 表示與達沃斯會議相關的費用約為 20 萬美元。她還表示，第一季度約 10 萬美元的費用可能不會從運營費用的角度延續。</p>
<h2>新指標旨在顯示平台活動和收入可見性</h2>
<p>Qian 引入了兩個新的業務指標：合同收入和平台投放計劃價值（PPPV）。</p>
<p>合同收入代表在未來期間預計確認的活躍保單上的合同承諾收入。Qian 表示，截至 3 月 31 日，2026 年剩餘三個季度的合同收入總計約為 2290 萬美元。包括第一季度報告的 880 萬美元，她表示 Health In Tech 預計在 2026 財年將從現有合同中報告 3170 萬美元的收入，未考慮每月調整。</p>
<p>PPPV 代表通過公司平台投放的自籌資金健康計劃的總合同價值，包括保費、索賠基金和管理費用。Qian 表示，Health In Tech 在 2026 年第一季度投放了 8200 萬美元的自籌資金止損計劃。</p>
<p>公司將停止使用之前的已註冊員工指標。Qian 表示，該指標未能充分反映覆蓋類型和計劃層級之間的差異，或員工變動（如僱傭、辭職和家庭狀態變化）的影響。</p>
<h2>管理層專注於經紀人、承運人和技術</h2>
<p>Johnson 表示，Health In Tech 計劃在多個領域部署資本：擴展銷售分銷網絡、增加承運人合作伙伴、增強技術架構和人工智能開發，以及推進服務和產品開發。</p>
<p>首席增長官 Zain Hasan 表示，公司內部銷售團隊主要專注於引導和激活分銷合作伙伴，而不是直接向僱主賬户銷售。他表示，Health In Tech 在 2025 年通過六人的內部銷售團隊創造了 3300 萬美元的收入，現在計劃選擇性地擴展該團隊。</p>
<p>在回應分析師提問時，Hasan 表示，公司打算招聘兩到三名專注於外向銷售的銷售代表，以提高經紀人對平台的認知。</p>
<p>約翰遜表示，增加更多的承運商合作伙伴很重要，因為這為經紀人提供了同一僱主集團的更多承保視角，從而增加了續約時獲得競爭性選擇的可能性。他表示，這可能會改善平台的使用率、僱主的留存率和收入增長。</p>
<p>該公司還在投資平台改進。約翰遜表示，Health In Tech 與亞馬遜網絡服務的高級服務合作伙伴 Cyclom 合作，以擴展前端和後端功能。他表示，這項工作旨在改善平台能力、報告、工作流程集成和數據基礎設施。</p>
<p>約翰遜還描述了公司 e-dibs 平台的更新，包括更新的界面、改進的工作流程設計、增強的人口統計洞察、擴展的大型團體報價功能、承保狀態可見性、自動化的經驗數據解析、基於人工智能的風險洞察以及平台內經紀人與承保人之間的消息傳遞。他表示，早期的經紀人反饋積極，特別是在消息傳遞和工作流程改進方面。</p>
<h2>三年費率穩定計劃進展</h2>
<p>Health In Tech 正在開發一項三年費率穩定計劃，旨在減少定價波動併為僱主集團提供更大的成本可預測性。約翰遜表示，公司預計將在 2026 年第二季度末至第三季度完成市場測試。</p>
<p>在問答環節中，約翰遜表示需求開始出現，公司已將該計劃修改為不依賴特定承運商。他表示，Health In Tech 開始提供提案，並 “預計至少會有一項” 協議在第二季度達成，儘管他警告説，直到完成之前一切都不是最終的。</p>
<p>錢表示，公司對該計劃的預測是保守的，並假設銷售將在第四季度開始，指出較大的團體通常在年末購買這類計劃。哈桑表示，該計劃針對較大的僱主，通常涉及較長的銷售週期，因為經紀人和僱主需要對結構感到舒適。</p>
<p>錢表示，三年計劃的收入確認將從生效日期起按月進行，公司將提供未來 36 個月合同收入的額外可見性。約翰遜表示，該計劃不需要預付押金。</p>
<p>約翰遜還表示，Health In Tech 預計將在第二季度開始初步的測試，推出一種數據驅動的解決方案，該方案整合心理數據和索賠數據，以為合作伙伴和僱主客户生成可操作的洞察。</p>
<h2>關於 Health In Tech NASDAQ: HIT</h2>
<p>Health in Tech, Inc 從事保險技術平台的提供，提供醫療行業流程的市場。其服務包括 Stone Mountain Risk、eDIYBS、HI Card、HI Performance Network 和附屬產品。該公司由蒂姆·約翰遜於 2014 年創立，總部位於佛羅里達州斯圖爾特。</p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Health In Tech 嗎？</h2>
<p>在考慮投資 Health In Tech 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 Health In Tech 並不在名單上。</p>
<p>雖然 Health In Tech 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Health In Tech (NASDAQ:HIT) 報告了 2026 年第一季度收入增長 9%，達到 880 萬美元，但淨虧損擴大至 160 萬美元。該公司正在增加對銷售和技術的投資，以爭取更大份額的自籌資金健康保險市場，該市場在大型企業中採用率更高。首席財務官 Julia Qian 指出，總運營費用上升至 670 萬美元，反映出向增長戰略的轉變。Health In Tech 重申其全年收入指導為 4500 萬美元至 5000 萬美元，表明潛在的年增長率為 35% 至 50%</p>

<p>Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.</p>
<div class="lb-trans"><p>Health In Tech NASDAQ: HIT 報告了 2026 年第一季度的收入增長和更大的虧損，管理層表示公司正在有意增加對銷售分銷、承運人關係和技術開發的投資，以追求更大份額的自籌資金健康保險市場。</p>
</div><p>Get <strong>Health In Tech</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Health In Tech</strong> 警報：</p>
</div><p>On the company’s earnings call, Chief Executive Officer Tim Johnson said Health In Tech is operating in what he described as a “massive, opaque” self-funded stop-loss insurance market, where adoption remains far higher among large businesses than among small and medium-sized employers. Citing industry estimates, Johnson said roughly 80% of large businesses had adopted self-funded health plans as of 2025, compared with about 27% of medium and small businesses.</p>
<div class="lb-trans"><p>在公司的財報電話會議上，首席執行官 Tim Johnson 表示，Health In Tech 正在一個他所描述的 “龐大且不透明” 的自籌資金止損保險市場中運營，在這個市場中，大型企業的採用率遠高於中小型企業。根據行業估計，Johnson 表示截至 2025 年，約 80% 的大型企業已採用自籌資金健康計劃，而中小型企業的比例約為 27%。</p>
</div><p>Johnson said the company’s AI-powered platform is designed to reduce the complexity of implementing self-funded plans. He said Health In Tech currently works with about 900 distribution partners, primarily insurance brokers, while the broader pool of insurance brokers exceeds 1 million, according to industry estimates.</p>
<div class="lb-trans"><p>Johnson 表示，公司基於人工智能的平台旨在減少實施自籌資金計劃的複雜性。他表示，Health In Tech 目前與約 900 個分銷合作伙伴合作，主要是保險經紀人，而根據行業估計，保險經紀人的總數超過 100 萬。</p>
</div><p>“Our penetration of the broker pool remains well below one-tenth of 1%, which highlights the significant runway potential ahead,” Johnson said.</p>
<div class="lb-trans"><p>“我們在經紀人池中的滲透率仍遠低於千分之一，這突顯了前方巨大的增長潛力，” Johnson 説。</p>
</div><h2>Revenue rises as company reiterates full-year outlook</h2>
<div class="lb-trans"><h2>收入增長，公司重申全年展望</h2>
</div><p>Chief Financial Officer Julia Qian said total revenue for the first quarter of 2026 was $8.8 million, up approximately 9% from the prior-year period. Adjusted EBITDA was negative $1.3 million, compared with positive $1.2 million a year earlier. Net loss was $1.6 million, compared with net income of $0.5 million in the prior-year period.</p>
<div class="lb-trans"><p>首席財務官 Julia Qian 表示，2026 年第一季度的總收入為 880 萬美元，比去年同期增長約 9%。調整後的 EBITDA 為負 130 萬美元，而去年同期為正 120 萬美元。淨虧損為 160 萬美元，而去年同期淨收入為 50 萬美元。</p>
</div><p>Qian said the slower revenue growth relative to prior periods reflected the current stage of scaling the business rather than a change in demand or platform scalability. She said revenue growth is tied to expansion of the distribution network, broker activity and conversion of pipeline opportunities, areas in which the company is investing during 2026.</p>
<div class="lb-trans"><p>Qian 表示，相較於之前的時期，收入增長放緩反映了當前業務擴展階段，而不是需求或平台可擴展性的變化。她表示，收入增長與分銷網絡的擴展、經紀人活動和管道機會的轉化相關，公司在 2026 年將對此進行投資。</p>
</div><p>Health In Tech reiterated its full-year 2026 revenue guidance of $45 million to $50 million, which Johnson said would represent approximately 35% to 50% year-over-year growth.</p>
<div class="lb-trans"><p>Health In Tech 重申其 2026 年全年收入指引為 4500 萬美元至 5000 萬美元，Johnson 表示這將代表約 35% 至 50% 的同比增長。</p>
</div><p>The company ended the quarter with $10.3 million in cash and cash equivalents, reflecting proceeds from a private investment in public equity, or PIPE, completed in March. Johnson said the financing brought in approximately $7 million in gross proceeds and was not driven by an immediate need for working capital. Instead, he said the company saw an opportunity to broaden its shareholder base and add capital for growth initiatives.</p>
<div class="lb-trans"><p>公司在季度末擁有 1030 萬美元的現金及現金等價物，反映了在 3 月份完成的公開股權私募投資（PIPE）的收益。Johnson 表示，此次融資帶來了約 700 萬美元的毛收益，並不是出於對營運資金的迫切需求。相反，他表示公司看到了擴大股東基礎和為增長計劃增加資本的機會。</p>
</div><h2>Operating expenses increase with planned investment</h2>
<div class="lb-trans"><h2>運營費用因計劃投資而增加</h2>
</div><p>Qian said total operating expenses were $6.7 million in the quarter, or approximately 76% of revenue, compared with $4.9 million, or 41% of revenue, in the prior-year period.</p>
<div class="lb-trans"><p>Qian 表示，季度總運營費用為 670 萬美元，約佔收入的 76%，而去年同期為 490 萬美元，約佔收入的 41%。</p>
</div><ul>
<li>Sales and marketing expenses were $2.3 million, or about 26% of revenue, up from $1.1 million, or 14% of revenue, in the prior-year period.</li>
<li>General and administrative expenses were $3.5 million, or approximately 39% of revenue, compared with $3.2 million, or 41% of revenue, a year earlier.</li>
<li>Research and development expenses were $0.9 million, or about 10% of revenue, compared with $0.5 million, or 7% of revenue, in the prior-year period.</li>
</ul>
<div class="lb-trans"><ul>
<li>銷售和營銷費用為 230 萬美元，約佔收入的 26%，高於去年同期的 110 萬美元，約佔收入的 14%。</li>
<li>一般和行政費用為 350 萬美元，約佔收入的 39%，而去年同期為 320 萬美元，約佔收入的 41%。</li>
<li>研發費用為 90 萬美元，約佔收入的 10%，而去年同期為 50 萬美元，約佔收入的 7%。</li>
</ul>
</div><p>Qian said the company also capitalized approximately $0.6 million of software development during the first quarter. She said overall expenses reflect a “purposeful shift in capital allocation” toward growth initiatives, and she expects elevated investment to continue throughout 2026.</p>
<div class="lb-trans"><p>Qian 表示，公司在第一季度還資本化了約 60 萬美元的軟件開發費用。她表示，整體費用反映了向增長計劃 “有目的的資本配置轉變”，並預計在 2026 年將繼續保持高水平的投資。</p>
</div><p>During the question-and-answer session, Qian said costs tied to the Davos conference were approximately $200,000. She also said about $100,000 of first-quarter costs likely would not carry forward from an operating expense perspective.</p>
<div class="lb-trans"><p>在問答環節中，Qian 表示與達沃斯會議相關的費用約為 20 萬美元。她還表示，第一季度約 10 萬美元的費用可能不會從運營費用的角度延續。</p>
</div><h2>New metrics aim to show platform activity and revenue visibility</h2>
<div class="lb-trans"><h2>新指標旨在顯示平台活動和收入可見性</h2>
</div><p>Qian introduced two new business metrics: contracted revenue and platform placed plan value, or PPPV.</p>
<div class="lb-trans"><p>Qian 引入了兩個新的業務指標：合同收入和平台投放計劃價值（PPPV）。</p>
</div><p>Contracted revenue represents contractually committed revenue on active policies that is expected to be recognized in future periods. Qian said that as of March 31, contracted revenue for the remaining three quarters of 2026 totaled approximately $22.9 million. Including the $8.8 million reported in the first quarter, she said Health In Tech estimated $31.7 million in revenue would be reported for fiscal 2026 from existing contracts, before monthly adjustments.</p>
<div class="lb-trans"><p>合同收入代表在未來期間預計確認的活躍保單上的合同承諾收入。Qian 表示，截至 3 月 31 日，2026 年剩餘三個季度的合同收入總計約為 2290 萬美元。包括第一季度報告的 880 萬美元，她表示 Health In Tech 預計在 2026 財年將從現有合同中報告 3170 萬美元的收入，未考慮每月調整。</p>
</div><p>PPPV represents the aggregate contractual value of self-funded health plans with stop-loss insurance placed through the company’s platform, including premium, claims fund and administrative fees. Qian said Health In Tech’s platform placed $82 million of self-funded stop-loss plans in the first quarter of 2026.</p>
<div class="lb-trans"><p>PPPV 代表通過公司平台投放的自籌資金健康計劃的總合同價值，包括保費、索賠基金和管理費用。Qian 表示，Health In Tech 在 2026 年第一季度投放了 8200 萬美元的自籌資金止損計劃。</p>
</div><p>The company is discontinuing its prior enrolled employee metric. Qian said that metric did not fully capture differences among coverage types and plan tiers, or the impact of employee changes such as hires, resignations and family status changes.</p>
<div class="lb-trans"><p>公司將停止使用之前的已註冊員工指標。Qian 表示，該指標未能充分反映覆蓋類型和計劃層級之間的差異，或員工變動（如僱傭、辭職和家庭狀態變化）的影響。</p>
</div><h2>Management focuses on brokers, carriers and technology</h2>
<div class="lb-trans"><h2>管理層專注於經紀人、承運人和技術</h2>
</div><p>Johnson said Health In Tech plans to deploy capital across several areas: expanding its sales distribution network, adding carrier partners, enhancing technology architecture and AI development, and advancing services and product development.</p>
<div class="lb-trans"><p>Johnson 表示，Health In Tech 計劃在多個領域部署資本：擴展銷售分銷網絡、增加承運人合作伙伴、增強技術架構和人工智能開發，以及推進服務和產品開發。</p>
</div><p>Chief Growth Officer Zain Hasan said the company’s in-house sales team is primarily focused on onboarding and activating distribution partners rather than directly selling to employer accounts. He said Health In Tech generated $33 million in revenue in 2025 with a six-person in-house sales team, and now plans to selectively expand that team.</p>
<div class="lb-trans"><p>首席增長官 Zain Hasan 表示，公司內部銷售團隊主要專注於引導和激活分銷合作伙伴，而不是直接向僱主賬户銷售。他表示，Health In Tech 在 2025 年通過六人的內部銷售團隊創造了 3300 萬美元的收入，現在計劃選擇性地擴展該團隊。</p>
</div><p>In response to an analyst question, Hasan said the company intends to hire two to three sales representatives focused on outbound efforts to increase broker awareness of the platform.</p>
<div class="lb-trans"><p>在回應分析師提問時，Hasan 表示，公司打算招聘兩到三名專注於外向銷售的銷售代表，以提高經紀人對平台的認知。</p>
</div><p>Johnson said adding more carrier partners is important because it gives brokers more underwriting perspectives for the same employer group, increasing the likelihood of a competitive option at renewal. He said that could improve platform utilization, employer retention and revenue growth.</p>
<div class="lb-trans"><p>約翰遜表示，增加更多的承運商合作伙伴很重要，因為這為經紀人提供了同一僱主集團的更多承保視角，從而增加了續約時獲得競爭性選擇的可能性。他表示，這可能會改善平台的使用率、僱主的留存率和收入增長。</p>
</div><p>The company is also investing in platform improvements. Johnson said Health In Tech engaged Cyclom, an Amazon Web Services advanced tier service partner, to expand front-end and back-end functionality. He said the work is intended to improve platform capabilities, reporting, workflow integration and data infrastructure.</p>
<div class="lb-trans"><p>該公司還在投資平台改進。約翰遜表示，Health In Tech 與亞馬遜網絡服務的高級服務合作伙伴 Cyclom 合作，以擴展前端和後端功能。他表示，這項工作旨在改善平台能力、報告、工作流程集成和數據基礎設施。</p>
</div><p>Johnson also described updates to the company’s e-dibs platform, including a refreshed interface, improved workflow design, enhanced census insights, expanded large group quoting functionality, underwriting status visibility, automated experience data parsing, AI-driven risk insights and broker-to-underwriter messaging inside the platform. He said early broker feedback has been positive, particularly around messaging and workflow improvements.</p>
<div class="lb-trans"><p>約翰遜還描述了公司 e-dibs 平台的更新，包括更新的界面、改進的工作流程設計、增強的人口統計洞察、擴展的大型團體報價功能、承保狀態可見性、自動化的經驗數據解析、基於人工智能的風險洞察以及平台內經紀人與承保人之間的消息傳遞。他表示，早期的經紀人反饋積極，特別是在消息傳遞和工作流程改進方面。</p>
</div><h2>Three-year rate stabilization program advances</h2>
<div class="lb-trans"><h2>三年費率穩定計劃進展</h2>
</div><p>Health In Tech is developing a three-year rate stabilization program designed to reduce pricing volatility and provide greater cost predictability for employer groups. Johnson said the company expects to complete market testing late in the second quarter into the third quarter of 2026.</p>
<div class="lb-trans"><p>Health In Tech 正在開發一項三年費率穩定計劃，旨在減少定價波動併為僱主集團提供更大的成本可預測性。約翰遜表示，公司預計將在 2026 年第二季度末至第三季度完成市場測試。</p>
</div><p>During the Q&amp;A session, Johnson said demand is beginning to emerge and that the company has modified the program to be carrier agnostic. He said Health In Tech is starting to provide proposals and is “anticipating at least one” agreement in the second quarter, though he cautioned that nothing is final until completed.</p>
<div class="lb-trans"><p>在問答環節中，約翰遜表示需求開始出現，公司已將該計劃修改為不依賴特定承運商。他表示，Health In Tech 開始提供提案，並 “預計至少會有一項” 協議在第二季度達成，儘管他警告説，直到完成之前一切都不是最終的。</p>
</div><p>Qian said the company’s forecast is conservative and assumes sales from the program beginning in the fourth quarter, noting that larger groups often purchase these types of plans toward year-end. Hasan said the program targets larger employers and typically involves a longer sales cycle as brokers and employers become comfortable with the structure.</p>
<div class="lb-trans"><p>錢表示，公司對該計劃的預測是保守的，並假設銷售將在第四季度開始，指出較大的團體通常在年末購買這類計劃。哈桑表示，該計劃針對較大的僱主，通常涉及較長的銷售週期，因為經紀人和僱主需要對結構感到舒適。</p>
</div><p>Qian said revenue recognition for a three-year program would remain monthly from the effective date, with the company providing additional visibility into future contracted revenue over the 36-month period. Johnson said the program would not require an upfront deposit.</p>
<div class="lb-trans"><p>錢表示，三年計劃的收入確認將從生效日期起按月進行，公司將提供未來 36 個月合同收入的額外可見性。約翰遜表示，該計劃不需要預付押金。</p>
</div><p>Johnson also said Health In Tech expects to begin initial beta testing in the second quarter of a data-driven solution that integrates psychological data and claims data to generate actionable insights for partners and employer clients.</p>
<div class="lb-trans"><p>約翰遜還表示，Health In Tech 預計將在第二季度開始初步的測試，推出一種數據驅動的解決方案，該方案整合心理數據和索賠數據，以為合作伙伴和僱主客户生成可操作的洞察。</p>
</div><h2>About Health In Tech NASDAQ: HIT</h2>
<div class="lb-trans"><h2>關於 Health In Tech NASDAQ: HIT</h2>
</div><p>Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.</p>
<div class="lb-trans"><p>Health in Tech, Inc 從事保險技術平台的提供，提供醫療行業流程的市場。其服務包括 Stone Mountain Risk、eDIYBS、HI Card、HI Performance Network 和附屬產品。該公司由蒂姆·約翰遜於 2014 年創立，總部位於佛羅里達州斯圖爾特。</p>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Health In Tech Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Health In Tech 嗎？</h2>
</div><p>Before you consider Health In Tech, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 Health In Tech 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 Health In Tech 並不在名單上。</p>
</div><p>While Health In Tech currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Health In Tech 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Health In Tech 第一季度財報電話會議要點